436 related articles for article (PubMed ID: 12698869)
1. Introduction and overview: recent advances in the immunotherapy of inflammatory bowel disease.
Hibi T; Inoue N; Ogata H; Naganuma M
J Gastroenterol; 2003 Mar; 38 Suppl 15():36-42. PubMed ID: 12698869
[TBL] [Abstract][Full Text] [Related]
2. Recent advances in biological therapy for inflammatory bowel disease.
Kurtovic J; Segal I
Trop Gastroenterol; 2004; 25(1):9-14. PubMed ID: 15303463
[TBL] [Abstract][Full Text] [Related]
3. Cytokine and anti-cytokine therapies for inflammatory bowel disease.
Ogata H; Hibi T
Curr Pharm Des; 2003; 9(14):1107-13. PubMed ID: 12769750
[TBL] [Abstract][Full Text] [Related]
4. Current concepts of the etiology and pathogenesis of ulcerative colitis and Crohn's disease.
Sartor RB
Gastroenterol Clin North Am; 1995 Sep; 24(3):475-507. PubMed ID: 8809232
[TBL] [Abstract][Full Text] [Related]
5. Gene transfer approaches for the treatment of inflammatory bowel disease.
Wirtz S; Neurath MF
Gene Ther; 2003 May; 10(10):854-60. PubMed ID: 12732871
[TBL] [Abstract][Full Text] [Related]
6. New insights into the immunopathology of chronic inflammatory bowel disease.
Ehrhardt RO
Semin Gastrointest Dis; 1996 Jul; 7(3):144-50. PubMed ID: 8817766
[TBL] [Abstract][Full Text] [Related]
7. Adacolumn for selective leukocytapheresis as a non-pharmacological treatment for patients with disorders of the immune system: an adjunct or an alternative to drug therapy?
Saniabadi AR; Hanai H; Suzuki Y; Ohmori T; Sawada K; Yoshimura N; Saito Y; Takeda Y; Umemura K; Kondo K; Ikeda Y; Fukunaga K; Nakashima M; Beretta A; Bjarnason I; Lofberg R
J Clin Apher; 2005 Oct; 20(3):171-84. PubMed ID: 15892107
[TBL] [Abstract][Full Text] [Related]
8. Immunotherapy of inflammatory bowel diseases: current concepts and future perspectives.
Neurath MF
Arch Immunol Ther Exp (Warsz); 2000; 48(2):81-4. PubMed ID: 10807047
[TBL] [Abstract][Full Text] [Related]
9. Inflammatory bowel disease. Current concepts of pathogenesis and implications for therapy.
Fiocchi C
Minerva Gastroenterol Dietol; 2002 Sep; 48(3):215-26. PubMed ID: 16491045
[TBL] [Abstract][Full Text] [Related]
10. [Standards, perspectives and limits of conservative therapy of chronic inflammatory bowel diseases].
Rogler G; Andus T; Schölmerich J
Zentralbl Chir; 1998; 123(4):316-24. PubMed ID: 9622888
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms and efficacy of immunobiologic therapies for inflammatory bowel diseases.
Ghosh N; Chaki R; Mandal V; Lin GD; Mandal SC
Int Rev Immunol; 2010; 29(1):4-37. PubMed ID: 20100080
[TBL] [Abstract][Full Text] [Related]
12. Cytokine tumor necrosis factor-alpha A promoter gene polymorphism at position -308 G-->A and pediatric inflammatory bowel disease: implications in ulcerative colitis and Crohn's disease.
Sýkora J; Subrt I; Dìdek P; Siala K; Schwarz J; Machalová V; Varvarovská J; Pazdiora P; Pozler O; Stozický F
J Pediatr Gastroenterol Nutr; 2006 May; 42(5):479-87. PubMed ID: 16707968
[TBL] [Abstract][Full Text] [Related]
13. An immunomodulation strategy targeted towards immunocompetent cells or cytokines in inflammatory bowel diseases (IBD).
Heresbach D; Sémana G; Gosselin M; Bretagne MG
Eur Cytokine Netw; 1999 Mar; 10(1):7-15. PubMed ID: 10210767
[TBL] [Abstract][Full Text] [Related]
14. Immune dysfunction in inflammatory bowel disease.
Neuman MG
Transl Res; 2007 Apr; 149(4):173-86. PubMed ID: 17383591
[TBL] [Abstract][Full Text] [Related]
15. Adsorptive depletion of elevated proinflammatory CD14+CD16+DR++ monocytes in patients with inflammatory bowel disease.
Hanai H; Iida T; Takeuchi K; Watanabe F; Yamada M; Kikuyama M; Maruyama Y; Iwaoka Y; Hirayama K; Nagata S; Takai K
Am J Gastroenterol; 2008 May; 103(5):1210-6. PubMed ID: 18177452
[TBL] [Abstract][Full Text] [Related]
16. [Biologic therapy of inflammatory bowel disease].
Baumgart DC; Wiedenmann B; Dignass AU
Z Gastroenterol; 2003 Oct; 41(10):1017-32. PubMed ID: 14562200
[TBL] [Abstract][Full Text] [Related]
17. Current dilemmas in the management of inflammatory bowel disease.
Rutgeerts P
Eur J Surg Suppl; 2002; (587):58-61. PubMed ID: 16144202
[TBL] [Abstract][Full Text] [Related]
18. Immunotherapy of Crohn's disease.
van Montfrans C; Camoglio L; van Deventer SJ
Mediators Inflamm; 1998; 7(3):149-52. PubMed ID: 9705600
[TBL] [Abstract][Full Text] [Related]
19. Novel strategies to attenuate immune activation in Crohn's disease.
Bamias G; Cominelli F
Curr Opin Pharmacol; 2006 Aug; 6(4):401-7. PubMed ID: 16753341
[TBL] [Abstract][Full Text] [Related]
20. [Chronic inflammatory bowel disease--current status].
Madsen JR; Laursen LS; Lauritsen K
Ugeskr Laeger; 1992 Aug; 154(33):2243-50. PubMed ID: 1413128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]